Sharks, beauty and synthetic biotech
Synthetic biotechnology is projected to surpass $61 billion in revenue by 2030, driven by companies interested in shifting sourcing strategies away from petrochemicals or practices harmful for biodiversity.
Previous
Previous
Ocean lovers festival launches with call for action on plastic
Next
Next